Quick Answer
China SXT Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $2.32 (loss) per share for the year ending 2025.
- China SXT Pharmaceuticals, Inc. showed an increase of +91.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from China SXT Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2017 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2017 to 2025), China SXT Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 4,033.9%.
- Historical annual values: Fiscal year 2025: $2.32 (loss) per share | Fiscal year 2024: $28.58 (loss) per share | Fiscal year 2023: $177.84 (loss) per share | Fiscal year 2022: $137.92 (loss) per share | Fiscal year 2021: $3.82 (loss) per share | Fiscal year 2019: $0.08 per share | Fiscal year 2018: $0.06 per share | Fiscal year 2017: $0.06 per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: